Most lately, it has been recognized that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds into a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts for a scavenger and does not activate a next mes… Read More